BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22330238)

  • 1. Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.
    Mohamed AF; Johnson FR; Hauber AB; Lescrauwaet B; Masterson A
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):419-26. PubMed ID: 22330238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stated preferences of physicians and chronic pain sufferers in the use of classic strong opioids.
    Chancellor J; Martin M; Liedgens H; Baker MG; Müller-Schwefe GH
    Value Health; 2012 Jan; 15(1):106-17. PubMed ID: 22264978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population.
    Jung CW; Tan J; Tan N; Kuo MN; Ashok A; Eells SJ; Miller LG
    J Gastroenterol Hepatol; 2010 Feb; 25(2):369-75. PubMed ID: 19929923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician preferences for medication attributes for the prophylactic treatment of patients with severe haemophilia A with inhibitors to factor VIII.
    Gelhorn H; Merikle E; Krishnan S; Nemes L; Leissinger C; Valentino L
    Haemophilia; 2013 Jan; 19(1):119-25. PubMed ID: 23005041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?
    Sung JJ; Amarapurkar D; Chan HL; Cheng J; Kao JH; Han KH; Piratvisuth T
    Antivir Ther; 2010; 15(4):607-16. PubMed ID: 20587854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' preferences towards coagulation factor concentrates in the treatment of Haemophilia with inhibitors: a discrete choice experiment.
    Lee WC; Joshi AV; Woolford S; Sumner M; Brown M; Hadker N; Pashos CL
    Haemophilia; 2008 May; 14(3):454-65. PubMed ID: 18282152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of race/ethnicity, sex, and social circumstances on coronary revascularization preferences: a vignette comparison.
    Barnhart JM; Wassertheil-Smoller S
    Cardiol Rev; 2006; 14(5):215-22. PubMed ID: 16924161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians.
    Gregorian RS; Gasik A; Kwong WJ; Voeller S; Kavanagh S
    J Pain; 2010 Nov; 11(11):1095-108. PubMed ID: 20452835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection.
    Kauf TL; Mohamed AF; Hauber AB; Fetzer D; Ahmad A
    Patient; 2012; 5(4):265-78. PubMed ID: 22775534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
    Brett Hauber A; Mohamed AF; Beam C; Medjedovic J; Mauskopf J
    J Viral Hepat; 2011 Sep; 18(9):619-27. PubMed ID: 20579276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and parent preferences for haemophilia A treatments.
    Mohamed AF; Epstein JD; Li-McLeod JM
    Haemophilia; 2011 Mar; 17(2):209-14. PubMed ID: 21070493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma.
    Wong MK; Mohamed AF; Hauber AB; Yang JC; Liu Z; Rogerio J; Garay CA
    J Med Econ; 2012; 15(6):1139-48. PubMed ID: 22808923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the eye of the beholder: preferences of patients, family physicians, and surgeons for lumbar spinal surgery.
    Bederman SS; Mahomed NN; Kreder HJ; McIsaac WJ; Coyte PC; Wright JG
    Spine (Phila Pa 1976); 2010 Jan; 35(1):108-15. PubMed ID: 20042962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' preferences and expectations in traumatic brain injury rehabilitation--results of a case-based questionnaire survey.
    Hasenbein U; Kuss O; Bäumer M; Schert C; Schneider H; Wallesch CW
    Disabil Rehabil; 2003 Feb; 25(3):136-42. PubMed ID: 12648003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of interferon alpha therapy on hepatitis B viral replication in patients with chronic hepatitis B: a meta-analysis.
    Yang YF; Zhao W; Xia HM; Zhong YD; Huang P; Wen J
    Antiviral Res; 2010 Feb; 85(2):361-5. PubMed ID: 19900483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.